Lenci I - Search Results

1

Hepatitis C virus RNA levels at week-2 of telaprevir/boceprevir administration are predictive of virological outcome.

Cento V, Di Paolo D, Di Carlo D, Micheli V, Tontodonati M, De Leonardis F, Aragri M, Antonucci FP, Di Maio VC, Mancon A, Lenci I, Manunta A, Taliani G, Di Biagio A, Nicolini LA, Nosotti L, Sarrecchia C, Siciliano M, Landonio S, Pellicelli A, Gasbarrini A, Vecchiet J, Magni CF, Babudieri S, Mura MS, Andreoni M, Parruti G, Rizzardini G, Angelico M, Perno CF, Ceccherini-Silberstein F. Cento V, et al. Among authors: lenci i. Dig Liver Dis. 2015 Feb;47(2):157-63. doi: 10.1016/j.dld.2014.11.010. Epub 2014 Nov 24. Dig Liver Dis. 2015. PMID: 25544656 Free article.

2

The Italian data on SARS-CoV-2 infection in transplanted patients support an organ specific immune response in liver recipients.

Rendina M, Barone M, Lillo C, Trapani S, Masiero L, Trerotoli P, Puoti F, Lupo LG, Tandoi F, Agnes S, Grieco A, Andorno E, Marenco S, Giannini EG, Baccarani U, Toniutto P, Carraro A, Colecchia A, Cescon M, Morelli MC, Cillo U, Burra P, Angeli P, Colledan M, Fagiuoli S, De Carlis L, Belli L, De Simone P, Carrai P, Di Benedetto F, De Maria N, Ettorre GM, Giannelli V, Gruttadauria S, Volpes R, Corsale S, Mazzaferro V, Bhoori S, Romagnoli R, Martini S, Rossi G, Caccamo L, Donato MF, Rossi M, Ginanni Corradini S, Spada M, Maggiore G, Tisone G, Lenci I, Vennarecci G, Tortora R, Vivarelli M, Svegliati Baroni G, Zamboni F, Mameli L, Tafuri S, Simone S, Gesualdo L, Cardillo M, Di Leo A. Rendina M, et al. Among authors: lenci i. Front Immunol. 2023 Jul 3;14:1203854. doi: 10.3389/fimmu.2023.1203854. eCollection 2023. Front Immunol. 2023. PMID: 37469512 Free PMC article.

3

Low-dose hepatitis B immunoglobulin given "on demand" in combination with lamivudine: a highly cost-effective approach to prevent recurrent hepatitis B virus infection in the long-term follow-up after liver transplantation.

Di Paolo D, Tisone G, Piccolo P, Lenci I, Zazza S, Angelico M. Di Paolo D, et al. Among authors: lenci i. Transplantation. 2004 Apr 27;77(8):1203-8. doi: 10.1097/01.tp.0000118904.63669.eb. Transplantation. 2004. PMID: 15114086

4

A randomized study on Peg-interferon alfa-2a with or without ribavirin in liver transplant recipients with recurrent hepatitis C.

Angelico M, Petrolati A, Lionetti R, Lenci I, Burra P, Donato MF, Merli M, Strazzabosco M, Tisone G. Angelico M, et al. Among authors: lenci i. J Hepatol. 2007 Jun;46(6):1009-17. doi: 10.1016/j.jhep.2006.12.017. Epub 2007 Feb 5. J Hepatol. 2007. PMID: 17328985 Clinical Trial.

5

Primary yolk sac tumor of the liver: incidental finding in a patient transplanted for hepatocellular carcinoma.

Lenci I, Tariciotti L, Baiocchi L, Manzia TM, Toti L, Craboledda P, Callea F, Angelico M, Tisone G. Lenci I, et al. Transpl Int. 2008 Jun;21(6):598-601. doi: 10.1111/j.1432-2277.2008.00667.x. Epub 2008 Mar 18. Transpl Int. 2008. PMID: 18363574 Free article.

6

Massive hepatic angiomyolipoma in a young woman with tuberous sclerosis complex: significant clinical improvement during tamoxifen treatment.

Lenci I, Angelico M, Tisone G, Orlacchio A, Palmieri G, Pinci M, Bombardieri R, Curatolo P. Lenci I, et al. J Hepatol. 2008 Jun;48(6):1026-9. doi: 10.1016/j.jhep.2008.01.036. Epub 2008 Mar 31. J Hepatol. 2008. PMID: 18436329 Free article.

7

Maintenance ribavirin monotherapy delays fibrosis progression in liver transplant recipients with recurrent hepatitis C at high risk of progression.

Lionetti R, Tisone G, Palmieri G, Almerighi C, Anselmo A, Tariciotti L, Lenci I, De Luca L, Monaco A, Angelico M. Lionetti R, et al. Among authors: lenci i. Dig Liver Dis. 2010 Apr;42(4):297-303. doi: 10.1016/j.dld.2009.08.008. Epub 2009 Oct 8. Dig Liver Dis. 2010. PMID: 19818696

8

Comment on the PROVE1 and PROVE2 clinical trials: "I was taking a picture of Rapid Virological Response with telaprevir, but the background is unfocused!".

Baiocchi L, Lenci I, Carbone M, Angelico M. Baiocchi L, et al. Among authors: lenci i. Hepatology. 2009 Nov;50(5):1676-7. doi: 10.1002/hep.23218. Hepatology. 2009. PMID: 19876945 No abstract available.

9

Patterns of chronic hepatitis B in Central Italy: a cross-sectional study.

Piccolo P, Lenci I, Telesca C, Di Paolo D, Bandiera F, De Melia L, Sorbello O, Renier G, Ricci GL, Nosotti L, Romano M, De Santis A, Levrero M, Antonucci G, Longo MA, Annicchiarico BE, Angelico M; Hep B Free Network Investigators. Piccolo P, et al. Among authors: lenci i. Eur J Public Health. 2010 Dec;20(6):711-3. doi: 10.1093/eurpub/ckp168. Epub 2009 Nov 2. Eur J Public Health. 2010. PMID: 19884157

10

A randomized controlled trial of pegylated interferon-alpha2a plus adefovir dipivoxil for hepatitis B e antigen-negative chronic hepatitis B.

Piccolo P, Lenci I, Demelia L, Bandiera F, Piras MR, Antonucci G, Nosotti L, Mari T, De Santis A, Ponti ML, Sorbello O, Iacomi F, Angelico M. Piccolo P, et al. Among authors: lenci i. Antivir Ther. 2009;14(8):1165-74. doi: 10.3851/IMP1466. Antivir Ther. 2009. PMID: 20032546 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

114 results

Search Page